2,3,5,4’-Tetrahydroxystilbene-2-O-b-D-Glucoside modulates CHEK2 and CCND1 alternative splicing to inhibit MCF-7 cells proliferation  

作　　者：Hui Shen You-Zhi Zhang Peng-Yu Wang Shuo Zhang Huan Pan Bei-Bei Liu Long-Sheng Xu Jian-Fen Shen 

机构地区：[1]Department of Central Laboratory,The First Affiliated Hospital of Jiaxing University,Jiaxing 314000,China [2]School of Pharmacy,Xianning Medical College,Hubei University of Science and Technology,Xianning 437100,China [3]Hubei Engineering Research Center of Traditional Chinese Medicine of South Hubei Province,Xianning Medical College,Hubei University of Science and Technology,Xianning 437100,China

出　　处：《Traditional Medicine Research》2024年第1期33-46,共14页TMR传统医学研究

基　　金：This research was funded by the Science and Technology Project of Jiaxing City(2019AD32251,2020AY30010);Scientific Research Foundation of Traditional Chinese Medicine of Zhejiang Province(2021ZB291);Medical Scientific Research Foundation of Zhejiang Province(2020KY9482019);the 2023 Jiaxing Key Discipline of Medicine-Clinical Diagnostics(Supporting Subject 2023-ZC-002);Project of Education Commission of Hubei Province(D20202802,B2022192).

摘　　要：Background:In our previous study,we observed a synergistic effect of 2,3,5,4’-Tetrahydroxystilbene-2-O-b-D-glucoside combined with adriamycin to induce apoptosis in MCF-7 breast cancer cells.However,the underlying mechanisms of epigenetic modifications,such as alternative splicing,have not been explored.In this study,we aimed to investigate the mechanism by which THSG inhibits MCF-7 cell proliferation using full-length transcriptome sequencing.Methods:First,cell viability was examined using the methyl thiazolyl tetrazolium method and full-length transcriptome sequencing was performed to identify genes and pathways.Gene Ontology and Kyoto Encyclopedia of Genes and Genomes were used to identify the principal pathways and targets of THSG.Flow cytometry analysis of cell cycle distribution was performed.Meanwhile,the analysis of alternative splicing and domains of the key proteins was conducted.Quantitative polymerase chain reaction and western blotting were performed for verification.Results:THSG showed significant cytotoxic activity in MCF-7 cells.Full-length transcriptome sequencing revealed differential alternative splicing with 173 upregulated and 263 downregulated genes.Further analysis identified distinct differential expression of genes(CHEK2-211 and CCND1-201)involved in the cell cycle in the THSG-treated group.Subsequently,alternative splicing types of CHEK2(mutually exclusive exon)and CCND1(intron retention).We found that THSG downregulated mRNA expression,as confirmed by quantitative polymerase chain reaction analysis.Interestingly,protein structural analysis revealed that THSG treatment led to the generation of CHK2-211,which was the result of a mutation in the amino acid residues(GLU-150,ASN-151)of the CHEK2 domain(VAL-150,GLY-151).and CyclinD1-201 were obtained when an amino acid(ASP-267)in the domain was lost in CyclinD1.Moreover,molecular docking analysis demonstrated that the domains of key proteins could bind THSG more effectively,with no difference in affinity.Western blotting confirmed that THSG

关 键 词：THSG breast cancer full-length transcriptome sequencing alternative splicing 

分 类 号：R737.9[医药卫生—肿瘤]